David J. King

Person

Encinitas, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies
- Patent number 12,129,303
- Issue date Oct 29, 2024
- Lassen Therapeutics 1, Inc.
- Robert A. Horlick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods comprising anti-NRP2 antibodies
- Patent number 12,065,495
- Issue date Aug 20, 2024
- Atyr Pharma, Inc.
- Luke G. Burman
- G01 - MEASURING TESTING
Information Patent Grant
Method of treating autoimmune disease with antibodies against IL-33
- Patent number 11,999,783
- Issue date Jun 4, 2024
- AnaptysBio, Inc.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compositions comprising anti-NRP2 antibodies
- Patent number 11,807,687
- Issue date Nov 7, 2023
- Atyr Pharma, Inc.
- Luke Burman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against T cell immunoglobulin and mucin protein...
- Patent number 11,753,472
- Issue date Sep 12, 2023
- Tesaro, Inc.
- David J. King
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 11,732,047
- Issue date Aug 22, 2023
- Momenta Pharmaceuticals, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods comprising anti-NRP2 antibodies
- Patent number 11,505,610
- Issue date Nov 22, 2022
- Atyr Pharma, Inc.
- Luke Burman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against T Cell immunoglobulin and mucin protein...
- Patent number 11,352,427
- Issue date Jun 7, 2022
- AnaptysBio, Inc.
- Marilyn Kehry
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 11,345,751
- Issue date May 31, 2022
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 11,155,624
- Issue date Oct 26, 2021
- AnaptysBio, Inc.
- David J. King
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treating pustular psoriasis with antibodies directed agai...
- Patent number 11,130,814
- Issue date Sep 28, 2021
- AnaptysBio, Inc.
- Peter Bowers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating inflammatory disorder with antibodies directed a...
- Patent number 10,836,820
- Issue date Nov 17, 2020
- AnaptysBio, Inc.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against lymphocyte activation gene 3 (LAG-3)
- Patent number 10,836,824
- Issue date Nov 17, 2020
- AnaptysBio, Inc.
- Helen Toni Jun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 10,738,117
- Issue date Aug 11, 2020
- AnaptysBio, Inc.
- David J. King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 10,676,526
- Issue date Jun 9, 2020
- Momenta Pharmaceuticals, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against interleukin 36 receptor (IL-36R)
- Patent number 10,526,410
- Issue date Jan 7, 2020
- AnaptysBio, Inc.
- Peter Bowers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against T cell immunoglobulin and mucin protein...
- Patent number 10,508,149
- Issue date Dec 17, 2019
- AnaptysBio, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against interleukin-33 (IL-33) and methods of m...
- Patent number 10,059,764
- Issue date Aug 28, 2018
- AnaptysBio, Inc.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against nerve growth factor (NGF)
- Patent number 9,951,126
- Issue date Apr 24, 2018
- AnaptysBio, Inc.
- David J. King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 9,815,897
- Issue date Nov 14, 2017
- AnaptysBio, Inc.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against IL-17
- Patent number 9,328,166
- Issue date May 3, 2016
- AnaptysBio, Inc.
- Robert Horlick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies directed against complement protein C5
- Patent number 9,133,269
- Issue date Sep 15, 2015
- AnaptysBio, Inc.
- Audrey McConnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against nerve growth factor (NGF)
- Patent number 8,926,978
- Issue date Jan 6, 2015
- AnaptysBio, Inc.
- David J. King
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-IL-11RA ANTIBODIES
- Publication number 20240425606
- Publication date Dec 26, 2024
- Lassen Therapeutics 1, Inc.
- Robert A. HORLICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL 18BP ANTIBODIES
- Publication number 20240417479
- Publication date Dec 19, 2024
- Lassen Therapeutics 1, Inc.
- Robert A. HORLICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
- Publication number 20240294631
- Publication date Sep 5, 2024
- ANAPTYSBIO, INC.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-IL-11RA ANTIBODIES
- Publication number 20240199753
- Publication date Jun 20, 2024
- Lassen Therapeutics 1, Inc.
- Robert A. HORLICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20240158508
- Publication date May 16, 2024
- MOMENTA PHARMACEUTICALS, INC.
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-...
- Publication number 20240158495
- Publication date May 16, 2024
- Tesaro, Inc.
- Helen Toni Jun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES
- Publication number 20240092917
- Publication date Mar 21, 2024
- aTyr Pharma, Inc.
- Luke BURMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein...
- Publication number 20230416368
- Publication date Dec 28, 2023
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Programmed Death-1(PD-1)
- Publication number 20230331843
- Publication date Oct 19, 2023
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES
- Publication number 20230312730
- Publication date Oct 5, 2023
- aTyr Pharma, Inc.
- Luke G. BURMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20230049725
- Publication date Feb 16, 2023
- MOMENTA PHARMACEUTICALS, INC.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20220363759
- Publication date Nov 17, 2022
- AnaplysBio, Inc
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20220169734
- Publication date Jun 2, 2022
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY AGENTS DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE-3 (LAG-...
- Publication number 20220135670
- Publication date May 5, 2022
- Tesaro, Inc.
- Helen Toni Jun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Programmed Death-1 (PD-1)
- Publication number 20220089739
- Publication date Mar 24, 2022
- Tesaro, Inc.
- David J. King
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)
- Publication number 20210388095
- Publication date Dec 16, 2021
- ANAPTYSBIO, INC.
- Peter BOWERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20210238275
- Publication date Aug 5, 2021
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES
- Publication number 20210163606
- Publication date Jun 3, 2021
- aTyr Pharma, Inc.
- Luke BURMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Programmed Death-1(PD-1)
- Publication number 20210163589
- Publication date Jun 3, 2021
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)
- Publication number 20210095026
- Publication date Apr 1, 2021
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
- Publication number 20210040198
- Publication date Feb 11, 2021
- ANAPTYSBIO, INC.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20200299382
- Publication date Sep 24, 2020
- Momenta Pharmaceuticals, Inc.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20200148770
- Publication date May 14, 2020
- ANAPTYSBIO, INC.
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)
- Publication number 20200087408
- Publication date Mar 19, 2020
- ANAPTYSBIO, INC.
- Peter BOWERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES
- Publication number 20190309076
- Publication date Oct 10, 2019
- aTyr Pharma Inc.
- Luke BURMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20190284280
- Publication date Sep 19, 2019
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)
- Publication number 20190256596
- Publication date Aug 22, 2019
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH- 1 (PD-1)
- Publication number 20190256600
- Publication date Aug 22, 2019
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
- Publication number 20180346562
- Publication date Dec 6, 2018
- ANAPTYSBIO, INC.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HRS ANTIBODIES AND COMBINATON THERAPIES FOR TREATING CANCERS
- Publication number 20180282402
- Publication date Oct 4, 2018
- aTyr Pharma, Inc.
- Ryan Andrew Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David J. King

Person

Patents Grantslast 30 patents

Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies

Compositions and methods comprising anti-NRP2 antibodies

Method of treating autoimmune disease with antibodies against IL-33

Therapeutic compositions comprising anti-NRP2 antibodies

Antibodies directed against T cell immunoglobulin and mucin protein...

FcRn antibodies and methods of use thereof

Compositions and methods comprising anti-NRP2 antibodies

Antibodies directed against T Cell immunoglobulin and mucin protein...

FcRn antibodies and methods of use thereof

Antibodies directed against programmed death-1 (PD-1)

Method of treating pustular psoriasis with antibodies directed agai...

Method of treating inflammatory disorder with antibodies directed a...

Antibodies directed against lymphocyte activation gene 3 (LAG-3)

Antibodies directed against programmed death-1 (PD-1)

FcRn antibodies and methods of use thereof

Antibodies directed against interleukin 36 receptor (IL-36R)

Antibodies directed against T cell immunoglobulin and mucin protein...

Antibodies directed against interleukin-33 (IL-33) and methods of m...

Antibodies directed against nerve growth factor (NGF)

Antibodies directed against programmed death-1 (PD-1)

Antibodies directed against IL-17

Humanized antibodies directed against complement protein C5

Antibodies directed against nerve growth factor (NGF)

Patents Applicationslast 30 patents

ANTI-IL-11RA ANTIBODIES

ANTI-IL 18BP ANTIBODIES

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

ANTI-IL-11RA ANTIBODIES

FcRn Antibodies and Methods of Use Thereof

Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-...

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein...

Antibodies Directed Against Programmed Death-1(PD-1)

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

FcRn Antibodies and Methods of Use Thereof

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODY AGENTS DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE-3 (LAG-...

Antibodies Directed Against Programmed Death-1 (PD-1)

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

FcRn Antibodies and Methods of Use Thereof

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

Antibodies Directed Against Programmed Death-1(PD-1)

Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

FcRn Antibodies and Methods of Use Thereof

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)

ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH- 1 (PD-1)

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

ANTI-HRS ANTIBODIES AND COMBINATON THERAPIES FOR TREATING CANCERS